Home / News & Events / florida / Centerstone’s Ketamine/Esketamine Program for Treatment-Resistant Depression featured on news broadcast

Centerstone’s Ketamine/Esketamine Program for Treatment-Resistant Depression featured on news broadcast

Centerstone’s new therapy program for individuals seeking treatment for severe depression was featured recently on WFLA-TV.

Through the program, Centerstone can offer Spravato, a nasal spray that contains the FDA-approved medication Esketamine, and ketamine infusion therapy for people who have been treated for depression with no improvement in symptoms.

To learn more about this program, please go online to centerstone.org/esketamine. To view this video, please click here.

Related Posts

Press Release
Bradenton, Fla. — Centerstone is working to address this barrier by offering alternative payment arrangements for in-patient addiction treatment ...
News
Press Release
Centerstone has produced a new video all about ObservSMART, a proximity-based monitoring system that has been added to its ...
Depression
Press Release
Centerstone, a national leader in behavioral health care, has introduced new therapies for individuals seeking treatment for severe depression. ...
Family Matters
Press Release
Centerstone’s Kathryn Graber was recently honored by Manatee Children’s Services as the James Wischer Child Advocate of the Year! ...
News
Press Release
Centerstone has announced the promotion of Roger Johnson to chief operating officer in Florida. Johnson previously served as regional ...

Call Now

Skip to content
Centerstone Logo
Centerstone
Customer.care@centerstone.org
1921 Ransom Place, Nashville, TN, 37217, US
877-467-3123
Centerstone Alton Office